当前位置: X-MOL 学术Tumori J. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society
Tumori Journal ( IF 1.9 ) Pub Date : 2023-01-06 , DOI: 10.1177/03008916221146820
Andrea Milani 1 , Valentina Tuninetti 2 , Sandro Pignata 3 , Domenica Lorusso 4 , Daniele Castaldo 5 , Ugo De Giorgi 6 , Antonella Savarese 7 , Nicoletta Biglia 8 , Giuseppa Scandurra 9 , Giorgia Mangili 10 , Massimo Di Maio 2 , Margherita Turinetto 2 , Marco Bellero 2 , Serafina Mammoliti 11 , Silvia Testa 12 , Giulia Scotto 2 , Andrea Purro 1 , Grazia Artioli 13 , Giorgio Valabrega 2
Affiliation  

Introduction:Low molecular weight heparin (LMWH) has been the backbone of the treatment of cancer associated thrombosis (CAT). Direct-acting oral anticoagulants (DOACs) have shown efficacy and safe...

中文翻译:

癌症相关血栓形成患者的抗凝药处方模式:MITO 小组和 AIOM 协会的调查结果

简介:低分子肝素(LMWH)一直是治疗癌症相关血栓(CAT)的支柱。直接作用口服抗凝剂(DOAC)已显示出有效性和安全性...
更新日期:2023-01-09
down
wechat
bug